EDAP to Participate in the 2024 Jefferies London Healthcare Conference
EDAP TMS SA (Nasdaq: EDAP), a leader in robotic energy-based therapies, has announced its participation in the upcoming 2024 Jefferies London Healthcare Conference. CEO Ryan Rhodes will present and conduct one-on-one investor meetings during the event, scheduled for November 19-21, 2024. The presentation is set for Tuesday, November 19, at 8:30-8:55 AM GMT at The Waldorf Hilton London. Both live and archived webcasts of the presentation will be available through the company's website's Investor section.
EDAP TMS SA (Nasdaq: EDAP), leader nelle terapie robotiche basate sull'energia, ha annunciato la sua partecipazione alla prossima Jefferies London Healthcare Conference 2024. Il CEO Ryan Rhodes presenterà e condurrà incontri individuali con gli investitori durante l'evento, programmato per il 19-21 novembre 2024. La presentazione si terrà martedì 19 novembre, dalle 8:30 alle 8:55 AM GMT presso il Waldorf Hilton di Londra. Sia il webcast in diretta che quello registrato della presentazione saranno disponibili nella sezione Investitori del sito web dell'azienda.
EDAP TMS SA (Nasdaq: EDAP), líder en terapias robóticas basadas en energía, ha anunciado su participación en la próxima Conferencia de Salud de Jefferies Londres 2024. El CEO Ryan Rhodes presentará y llevará a cabo reuniones individuales con inversores durante el evento, programado para el 19-21 de noviembre de 2024. La presentación está programada para el martes 19 de noviembre, de 8:30 a 8:55 AM GMT en el Waldorf Hilton de Londres. Tanto la transmisión en vivo como las grabaciones de la presentación estarán disponibles a través de la sección de Inversores del sitio web de la empresa.
EDAP TMS SA (Nasdaq: EDAP), 로봇 에너지 기반 치료의 선두주자,가 곧 열릴 2024 제퍼리스 런던 헬스케어 컨퍼런스에 참가한다고 발표했습니다. CEO 라이언 로즈가 행사 동안 발표를 하고 투자자들과의 일대일 회의를 진행할 예정이며, 이 행사는 2024년 11월 19일부터 21일까지 예정되어 있습니다. 발표는 11월 19일 화요일 오전 8시 30분부터 8시 55분(GMT)까지 런던의 월도프 힐튼에서 진행됩니다. 회사 웹사이트의 투자자 섹션을 통해 발표의 실시간 및 기록된 웹캐스트를 이용할 수 있습니다.
EDAP TMS SA (Nasdaq: EDAP), un leader dans les thérapies robotiques basées sur l'énergie, a annoncé sa participation à la prochaine Conférence de Santé Jefferies à Londres 2024. Le PDG Ryan Rhodes présentera et mènera des réunions individuelles avec des investisseurs lors de l'événement, prévu du 19 au 21 novembre 2024. La présentation aura lieu le mardi 19 novembre, de 8h30 à 8h55 GMT au Waldorf Hilton de Londres. Les webcasts en direct et archivés de la présentation seront disponibles dans la section Investisseurs du site Web de l'entreprise.
EDAP TMS SA (Nasdaq: EDAP), führend in robotergestützten energie-basierten Therapien, hat seine Teilnahme an der bevorstehenden Jefferies London Healthcare Conference 2024 angekündigt. CEO Ryan Rhodes wird während der Veranstaltung, die vom 19. bis 21. November 2024 stattfindet, präsentieren und Einzelgespräche mit Investoren führen. Die Präsentation findet am Dienstag, den 19. November, von 8:30 bis 8:55 Uhr GMT im Waldorf Hilton in London statt. Sowohl Live- als auch archivierte Webcasts der Präsentation werden im Investorenbereich der Unternehmenswebsite verfügbar sein.
- None.
- None.
LYON, France, November 6, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, announced that Ryan Rhodes, Chief Executive Officer, is scheduled to present and host 1x1 investor meetings at the Jefferies London Healthcare Conference, which is being held November 19-21, 2024.
Date: Tuesday, November 19
Time: 8:30-8:55 AM GMT
Location: The Waldorf Hilton London
Webcast: LINK
The live and archived webcast of the presentation can be accessed in the Investors section of the Company’s website here.
About EDAP TMS SA
A recognized leader in the global therapeutic ultrasound market, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various pathologies using ultrasound technology. By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One® in Europe and in the U.S. as an answer to all requirements for ideal prostate tissue ablation. With the addition of the ExactVu™ Micro-Ultrasound device, EDAP TMS is now the only company offering a complete solution from diagnostics to focal treatment of Prostate Cancer. EDAP TMS also produces and distributes other medical equipment including the Sonolith® i-move lithotripter and lasers for the treatment of urinary tract stones using extra-corporeal shockwave lithotripsy (ESWL). For more information on the Company, please visit http://www.edap-tms.com, us.hifu-prostate.com and www.focalone.com.
Company Contact
Blandine Confort
Investor Relations / Legal Affairs
EDAP TMS SA
+33 4 72 15 31 50
bconfort@edap-tms.com
Investor Contact
John Fraunces
LifeSci Advisors, LLC
(917) 355-2395
jfraunces@lifesciadvisors.com
FAQ
When is EDAP presenting at the 2024 Jefferies London Healthcare Conference?
Where will the 2024 Jefferies London Healthcare Conference featuring EDAP take place?
How can investors watch EDAP's presentation at the Jefferies Healthcare Conference?
What activities will EDAP participate in at the 2024 Jefferies London Healthcare Conference?
